Free Trial

Next Century Growth Investors LLC Buys Shares of 2,215 Axon Enterprise, Inc. (NASDAQ:AXON)

Axon Enterprise logo with Aerospace background
Remove Ads

Next Century Growth Investors LLC acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 2,215 shares of the biotechnology company's stock, valued at approximately $1,316,000.

A number of other institutional investors have also recently made changes to their positions in the business. Alliancebernstein L.P. lifted its holdings in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after purchasing an additional 812,337 shares during the period. Norges Bank acquired a new stake in Axon Enterprise during the 4th quarter worth about $482,081,000. GQG Partners LLC purchased a new position in shares of Axon Enterprise during the 4th quarter valued at about $478,349,000. Vanguard Group Inc. lifted its holdings in shares of Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after buying an additional 275,959 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in shares of Axon Enterprise by 82.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 551,197 shares of the biotechnology company's stock worth $327,587,000 after buying an additional 249,513 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Trading Down 1.5 %

Axon Enterprise stock traded down $8.62 during mid-day trading on Thursday, hitting $563.23. The company's stock had a trading volume of 280,883 shares, compared to its average volume of 792,967. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $43.16 billion, a PE ratio of 145.54, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. The stock's fifty day moving average is $560.83 and its two-hundred day moving average is $563.13.

Remove Ads

Analysts Set New Price Targets

AXON has been the subject of several recent research reports. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Finally, Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $626.45.

Get Our Latest Stock Analysis on Axon Enterprise

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 6.10% of the company's stock.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads